# Clario Inc – FDA Inspection, Jan 10, 2022

Source: https://www.keypedia.com/records/fda_inspections/clario-inc/d437c25c-9ae1-4b1b-9906-4383651c7804
Source feed: FDA_Inspections

> FDA inspection 1161294 of Clario Inc, January 10, 2022. Classification: No Action Indicated (NAI). 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1161294
- Company Name: Clario Inc
- Inspection Date: 2022-01-10
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1171672 - 2022-05-12](https://www.keypedia.com/records/fda_inspections/clario-inc/09bed324-77a0-4102-8526-8c5978366a4f)
- [FDA Inspection 1163670 - 2022-03-04](https://www.keypedia.com/records/fda_inspections/clario-inc/84ea860f-0198-48c2-a56b-d76d5c5821ad)
- FDA Inspection 1136432 - 2021-02-05
- FDA Inspection 1106258 - 2019-09-26
- FDA Inspection 1014836 - 2017-06-08

Company: https://www.keypedia.com/companies/clario-inc/8f2d1f68-f3d8-4389-8100-efca010d9051

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c